Neuropathology of old-age dementia
|
|
- Stewart Underwood
- 5 years ago
- Views:
Transcription
1 Australian Association of Gerontology Adelaide, September Neuropathology of old-age dementia University of Cambridge, Institute of Public Health Suvi R. K. Hokkanen, MD MPH
2 Dementia types Alzheimer s dementia Dementia with Lewy Bodies Vascular Dementia Frontotemporal dementia Dementia in Parkinson s Disease Mixed Other? Alzheimer s and Vascular Dementia 2/2014
3 Estimated increase Dementia in percentage prevalence of the 80+ population Percentage Men (%) Women (%) Age group CFAS I, England and Wales, United Nations, Department of Economic and Social Affairs, Population Division (2011)
4 Challenges of dementia diagnosis in the older old Cognitive decline viewed as normal aging Comorbidities, medications Lack of normative neuropsychological data Limitations of standard diagnostic criteria
5 Dementia in the oldest old Alzheimer s dementia Dementia with Lewy Bodies Vascular Dementia Frontotemporal dementia Dementia in Parkinson s Disease Mixed Other? Alzheimer s and Vascular Dementia 2/2014
6 Nueuropathology of dementia Kril. Nat Rev Neurol 2009; Spillantini et al. Nature 1997; Ferrer. J Neurol Sci 2010; Alafuzoff. Exp Gernotol. 2012
7 Bias in pathological studies???
8 MRC Cognitive Function and Ageing Study (CFAS) - start in year olds - Oxford, Ely, Nottingham, Gwynedd, Liverpool, Newcastle
9 MRC Cognitive Function and Ageing Study (CFAS) n= start in year olds - Oxford, Ely, Nottingham, Gwynedd, Liverpool, Newcastle
10 MRC Cognitive Function and Ageing Study (CFAS) n= follow-up - start in year olds - Oxford, Ely, Nottingham, Gwynedd, Liverpool, Newcastle - interviews - cognitive examinations
11 MRC Cognitive Function and Ageing Study (CFAS) n= follow-up n= start in year olds - Oxford, Ely, Nottingham, Gwynedd, Liverpool, Newcastle - interviews - cognitive examinations - fixed / frozen - CERAD protocol
12 Neuropathological Diagnosis Prevalence of diagnosis (%) Normal brain Insufficient plaques and tangles Alzheimer's disease Parkinson's disease Cortical Insufficient Lewy bodies cortical Lewy bodies Vascular disease Others MRC CFAS. Lancet 2001
13 Neuropathological Diagnosis Prevalence of diagnosis (%) Normal brain Insufficient Alzheimer'sParkinson's plaques and tangles disease disease Cortical Lewy bodies Insufficient cortical Lewy bodies Vascular disease Others Dementia No dementia MRC CFAS. Lancet 2001
14 Neocortical AD pathology and age MRC CFAS. Lancet 2001.
15 Case report age: MMSE: medication: antihypertensiva donepezil memantine IADL ADL 12/ /2014
16 Case report AD type pathology expected in autopsy neurofibrillary tangles neuritic plaques Braak stage CERAD score neuropil threads www. translationalscience.msu.edu 12/2014
17 Case report Pathological examination: CERAD neuritic plaque score: 0 Braak stage for neurofibrillary tangles: II No significant vascular pathology
18 Case report Pathological examination: Univ. of British Columbia Neuroanatomy 2/2014 S. Hunter, S. Hokkanen
19 Old-age hippocampal sclerosis is a cause of dementia Normal CA1 Hippocampal sclerosis (HScl) CA2 CA1 CA3 CA4 CA1 Subiculum S. Hunter
20 Characteristics of HScl clinical presentation prevalence pathology genetics
21 Characteristics of HScl Alzheimer s type 46% 27% 9% 9% 9% Alzheimer s type and vascular Vascular Depressive illness prevalence No dementia pathology genetics
22 Characteristics of HScl 46% 27% 9% 9% 9% Alzheimer s type Alzheimer s type and vascular Vascular Depressive illness No dementia pathology genetics
23 Characteristics of HScl 46% 27% 9% 9% 9% Alzheimer s type Alzheimer s type and vascular Vascular Depressive illness No dementia Prevalence of TDP-43 genetics
24 Characteristics of HScl 46% 27% 9% 9% 9% Alzheimer s type Alzheimer s type and vascular Vascular Depressive illness No dementia Prevalence of TDP-43 non-hscl HScl statistic GRN rs5848 genotype, n CC CT TT χ 2 = 8.30 p= allelic frequency C T χ 2 = 6.20 p= 0.013
25 Take-home messages With increasing age, dissociation of clinical and pathological findings With increasing age, more mixed pathology Population-based clinicopathological studies are an invaluable research resource HScl presents clinically similar to AD, but associates pathologically with TDP-43
26 Thank you! University of Cambridge: Prof Carol Brayne Ms Sally Hunter Dr Fiona Matthews Dr Thais Minett University of Sheffield: Prof Paul Ince Prof Stephen Wharton Newcastle University: Dr Tuomo Polvikoski University of South Australia: Dr Hannah Keage University of Helsinki: Dr Liisa Myllykangas Ms Anna Raunio Ms Mia Kero
Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA
Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal
More informationAge, Neuropathology, and Dementia
The new england journal of medicine original article Age, Neuropathology, and Dementia George M. Savva, Ph.D., Stephen B. Wharton, F.R.C.Path., Paul G. Ince, M.D., Gillian Forster, B.Sc., Fiona E. Matthews,
More informationNeuropathology of Neurodegenerative Disorders Prof. Jillian Kril
Neurodegenerative disorders to be discussed Alzheimer s disease Lewy body diseases Frontotemporal dementia and other tauopathies Huntington s disease Motor Neuron Disease 2 Neuropathology of neurodegeneration
More informationRole of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases
Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer
More informationAlzheimer s Disease without Dementia
Alzheimer s Disease without Dementia Dr Emer MacSweeney CEO & Consultant Neuroradiologist Re:Cognition Health London Osteopathic Society 13 September 2016 Early diagnosis of Alzheimer s Disease How and
More informationType 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky
Type 2 Diabetes and Brain Disease in Older Adults Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky Disclosures to Participants Requirements for Successful Completion: For successful completion,
More informationADNI and DIAN Neuropathology Core
NI and DIAN Neuropathology Core Update October 14, 2016 Nigel Cairns, PhD, FRCPath Knight RC Neuropathology Core Leader NI Participants Autopsied per Funding Period Autopsy rates for NI1, NI GO, and NI2
More informationDementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology
Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language
More informationdoi: /brain/awq141 Brain 2010: 133; Age, Alzheimer s disease and dementia in the Baltimore Longitudinal Study of Ageing
doi:10.1093/brain/awq141 Brain 2010: 133; 2225 2231 2225 BRAIN A JOURNAL OF NEUROLOGY Age, Alzheimer s disease and dementia in the Baltimore Longitudinal Study of Ageing David Dolan, 1 Juan Troncoso, 2
More informationWHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient
DEMENTIA WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of
More informationExamining the influence of gender, education, social class and birth cohort on MMSE tracking over time: a population-based prospective cohort study
Matthews et al. BMC Geriatrics 2012, 12:45 RESEARCH ARTICLE Open Access Examining the influence of gender, education, social class and birth cohort on MMSE tracking over time: a population-based prospective
More informationFrontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer s disease
International Psychogeriatrics: page 1 of 8 C 2009 International Psychogeriatric Association doi:10.1017/s1041610209009454 Frontotemporal dementia and dementia with Lewy bodies in a case-control study
More informationSynaptic changes in dementia: links to cognition and behaviour
Synaptic changes in dementia: links to cognition and behaviour Paul T Francis, PhD Professor of Neurochemistry Director, Brains for Dementia Research Agenda Discuss synaptic changes in various dementias
More informationBMC Public Health. Open Access. Abstract. BioMed Central
BMC Public Health BioMed Central Research article An investigation of whether factors associated with short-term attrition change or persist over ten years: data from the Medical Research Council Cognitive
More informationBrain Bank of the Brazilian Aging Brain Study Group a Collection Focused in Human Control Cases
Brain Bank of the Brazilian Aging Brain Study Group a Collection Focused in Human Control Cases Lea Tenenholz Grinberg, M.D, Ph.D Associate Professor of Pathology University of the City of São Paulo Medical
More informationNIH Public Access Author Manuscript Arch Neurol. Author manuscript; available in PMC 2012 June 19.
NIH Public Access Author Manuscript Published in final edited form as: Arch Neurol. 2007 August ; 64(8): 1193 1196. doi:10.1001/archneur.64.8.1193. Dissociation of Neuropathologic Findings and Cognition:
More informationDISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT
Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease
More informationCommunity environment, cognitive impairment and dementia in later life: results from the Cognitive Function and Ageing Study
Community environment, cognitive impairment and dementia in later life: results from the Cognitive Function and Ageing Study Authors Yu-Tzu Wu 1, A. Matthew Prina 1, 2, Andy Jones 3, Linda E. Barnes 1,
More informationORIGINAL CONTRIBUTION. Cerebrospinal Fluid -Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic
ORIGINAL CONTRIBUTION Cerebrospinal Fluid -Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain Tero Tapiola, MD, PhD; Irina Alafuzoff, MD, PhD; Sanna-Kaisa Herukka,
More informationThe ABCs of Dementia Diagnosis
The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What
More informationImproving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018
Improving diagnosis of Alzheimer s disease and lewy body dementia Brain TLC October 2018 Plan for this discussion: Introduction to AD and LBD Why do we need to improve diagnosis? What progress has been
More informationDementia is not normal aging!
The Future of Alzheimer s Disease Treatment Adam L. Boxer, MD, PhD Director, Alzheimer s Disease Clinical Trials Program Memory and Aging Center Assistant Professor of Neurology University of California,
More informationdoi: /brain/aws234 Brain 2012: 135;
doi:10.1093/brain/aws234 Brain 2012: 135; 3005 3014 3005 BRAIN A JOURNAL OF NEUROLOGY Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies J. A. Schneider,
More informationDementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician
Dementia Aetiology, pathophysiology and the role of neuropsychological testing Dr Sheng Ling Low Geriatrician Topics to cover Why is dementia important What is dementia Differentiate between dementia,
More informationOLD AGE PSYCHIATRY. Dementia definition TYPES OF DEMENTIA. Other causes. Psychiatric disorders of the elderly. Dementia.
Psychiatric disorders of the elderly OLD AGE PSYCHIATRY Dementia Depression Delusional disorder/late onset schizophrenia Delirium Dementia definition LOCALISATION OF CEREBRAL FUNCTION Impairment of multiple
More informationPopulation-based analysis of pathological correlates of dementia in the oldest old
RESEARCH ARTICLE Population-based analysis of pathological correlates of dementia in the oldest old Maarit Tanskanen, Mira M akel a, Irma-Leena Notkola, Liisa Myllykangas, Sari Rastas, Minna Oinas, Perttu
More informationRe-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
Hunter et al. Alzheimer's Research & Therapy (2015) 7:57 DOI 10.1186/s13195-015-0141-2 RESEARCH Open Access Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and
More informationThe relationship between attitude, diagnosis and management of dementia in rural General Practice
The relationship between attitude, diagnosis and management of dementia in rural General Practice Alzheimer s Australia 14 th National Conference May 2011 Angela Greenway Crombie PhD Candidate Supervisors:
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (Review of TA 111) Appraisal
More informationOverview of neurological changes in Alzheimer s disease. Eric Karran
Overview of neurological changes in Alzheimer s disease Eric Karran Alzheimer s disease Alois Alzheimer 1864-1915 Auguste D. 1850-1906 Case presented November 26 th 1906 Guildford Talk.ppt 20 th March,
More informationDementia and Healthy Ageing : is the pathology any different?
Dementia and Healthy Ageing : is the pathology any different? Professor David Mann, Professor of Neuropathology, University of Manchester, Hope Hospital, Salford DEMENTIA Loss of connectivity within association
More informationRecent publications using the NACC Database. Lilah Besser
Recent publications using the NACC Database Lilah Besser Data requests and publications Using NACC data Number of requests by year Type 2009 2010 2011 2012 2013 2014 2015 Data files* 55 85 217 174 204
More informationAppendix K: Evidence review flow charts
K.1 Dementia diagnosis K.1.1 Dementia diagnosis What are the most effective methods of primary assessment to decide whether a person with suspected dementia should be referred to a dementia service? What
More informationForm A3: Subject Family History
Initial Visit Packet NACC Uniform Data Set (UDS) Form A: Subject Family History ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by a clinician
More informationNACC Neuropathology (NP) Diagnosis Coding Guidebook
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu
More informationALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health
ALZHEIMER S DISEASE OVERVIEW Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health Prevalence AD: DEMOGRAPHY AND CLINICAL FEATURES Risk and protective factors Clinical features and
More informationAutopsy Committee Sample Autopsy Case. Alzheimer Disease. Authors Ashley Thorburn, MD. Joseph E. Parisi, MD Autopsy Committee
Autopsy Committee Sample Autopsy Case Alzheimer Disease Authors Ashley Thorburn, MD Joseph E. Parisi, MD Autopsy Committee Clinical Summary: A 75-year-old man presented to his primary care physician with
More informationNIH Public Access Author Manuscript Arch Neurol. Author manuscript; available in PMC 2013 April 03.
NIH Public Access Author Manuscript Published in final edited form as: Arch Neurol. 2012 October ; 69(10): 1326 1331. doi:10.1001/archneurol.2012.1608. Pathologic Accumulation of α-synuclein and Aβ in
More informationThe Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease
The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease AIBL: Two site collaborative study Study is conducted at two sites: Perth
More informationNIH Public Access Author Manuscript Alzheimer Dis Assoc Disord. Author manuscript; available in PMC 2010 April 1.
NIH Public Access Author Manuscript Published in final edited form as: Alzheimer Dis Assoc Disord. 2009 ; 23(2): 152 157. The Effect of APOE-ε4 on Dementia is Mediated by Alzheimer Neuropathology James
More informationDavis et al. BMC Geriatrics 2014, 14:87
Davis et al. BMC Geriatrics 2014, 14:87 RESEARCH ARTICLE Open Access The descriptive epidemiology of delirium symptoms in a large population-based cohort study: results from the Medical Research Council
More informationOpinion 18 December 2013
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 18 December 2013 AMYVID 800 MBq/ml solution for injection 10 ml vial (CIP: 34009 585 065 4 3) 15 ml vial (CIP: 34009
More informationV ascular dementia is recognised as one of the most common
PAPER Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss J J Kril, S Patel, A J Harding, G M Halliday... See end of article for authors affiliations...
More informationThe Revised National Alzheimer s Coordinating Center s Neuropathology Form Available Data and New Analyses
J Neuropathol Exp Neurol Vol. 77, No. 8, August 2018, pp. 717 726 doi: 10.1093/jnen/nly049 ORIGINAL ARTICLE The Revised National Alzheimer s Coordinating Center s Neuropathology Form Available Data and
More informationDementia and cognitive decline
Dementia and cognitive decline Expert Briefing Su Ray and Dr Susan Davidson Research Department Together, we can help everyone to love later life 01 Brain basics Normal ageing, cognitive impairment and
More informationTDP-43 stage, mixed pathologies, and clinical Alzheimer s-type dementia
doi:10.1093/brain/aww224 BRAIN 2016: 139; 2983 2993 2983 TDP-43 stage, mixed pathologies, and clinical Alzheimer s-type dementia Bryan D. James, 1 Robert S. Wilson, 2,3 Patricia A. Boyle, 3 John Q. Trojanowski,
More informationNACC Minimum Data Set (MDS) Public Data Element Dictionary
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu
More informationPrevalence of mixed pathologies in the aging brain
Rahimi and Kovacs Alzheimer's Research & Therapy 2014, 6:82 REVIEW Prevalence of mixed pathologies in the aging brain Jasmin Rahimi and Gabor G Kovacs * Abstract The spectrum of mixed brain pathologies
More informationAltered proteins in the aging brain
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1182 Altered proteins in the aging brain ADILA ELOBEID ACTA UNIVERSITATIS UPSALIENSIS UPPSALA 2016 ISSN 1651-6206 ISBN
More informationEvaluation and Treatment of Dementia
Evaluation and Treatment of Dementia Jeffrey M. Burns, MD Edward H. Hashinger Professor of Neurology Co-Director, KU Alzheimer s Disease Center Director, Clinical and Translational Science Unit Disclosures
More informationNeuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy- Confirmed Dementia With Lewy Bodies
Article Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy- Confirmed Dementia With Lewy Bodies Clive G. Ballard, M.R.C.Psych., M.D. Robin Jacoby, F.R.C.Psych.,
More informationDementia and Alzheimer s disease
Since 1960 Medicine Korat โรงพยาบาลมหาราชนครราชส มา Dementia and Alzheimer s disease Concise Reviews PAWUT MEKAWICHAI MD DEPARTMENT of MEDICINE MAHARAT NAKHON RATCHASIMA HOSPITAL 1 Prevalence Increase
More informationRisk Factors for Dementia and MCI in the Oldest Old The 90+ Study
Risk Factors for Dementia and MCI in the Oldest Old The 90+ Study Claudia H. Kawas, M.D. January 18, 2015 Department of Neurology Department of Neurobiology & Behavior Institute for Memory Impairment &
More informationAccuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005Y2010
J Neuropathol Exp Neurol Copyright Ó 2012 by the American Association of Neuropathologists, Inc. Vol. 71, No. 4 April 2012 pp. 266Y273 ORIGINAL ARTICLE Accuracy of the Clinical Diagnosis of Alzheimer Disease
More informationCaring Sheet #11: Alzheimer s Disease:
CARING SHEETS: Caring Sheet #11: Alzheimer s Disease: A Summary of Information and Intervention Suggestions with an Emphasis on Cognition By Shelly E. Weaverdyck, PhD Introduction This caring sheet focuses
More informationAbnormal Facehand Testing is Associated with Anosognosia in Patients with Neuropathologicallyconfirmed Alzheimer s Disease
Abnormal Facehand Testing is Associated with Anosognosia in Patients with Neuropathologicallyconfirmed Alzheimer s Disease Item Type Thesis Authors Derksen, Brenna Publisher The University of Arizona.
More informationDementia. Assessing Brain Damage. Mental Status Examination
Dementia Assessing Brain Damage Mental status examination Information about current behavior and thought including orientation to reality, memory, and ability to follow instructions Neuropsychological
More informationYin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre
Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre Today Introduction to CT Introduction to MRI Introduction to nuclear medicine Imaging the dementias The Brain ~ 1.5
More informationCognitive impairment in older people: its implications for future demand for services and costs.
PSSRU Discussion Paper 1728 Cognitive impairment in older people: its implications for future demand for services and costs. Adelina Comas-Herrera 1, Raphael Wittenberg 1, Linda Pickard 1, Martin Knapp
More informationORIGINAL CONTRIBUTION. Apolipoprotein E 4 Is a Determinant for Alzheimer-Type Pathologic Features in Tauopathies, Synucleinopathies,
ORIGINAL CONTRIBUTION Apolipoprotein E 4 Is a Determinant for Alzheimer-Type Pathologic Features in Tauopathies, Synucleinopathies, and Frontotemporal Degeneration Keith A. Josephs, MST, MD; Yoshio Tsuboi,
More informationAlzheimer s Disease Update: From Treatment to Prevention
Alzheimer s Disease Update: From Treatment to Prevention Jeffrey M. Burns, MD Edward H. Hashinger Professor of Medicine Co-Director, KU Alzheimer s Disease Center Director, Clinical and Translational Science
More informationLessons from the Oldest Old: The 90+ Study Dana Greenia, R.N., M.S. Co-Investigator American Association of Orthodontists April 30, 2016
Lessons from the Oldest Old: The 90+ Study Dana Greenia, R.N., M.S. Co-Investigator American Association of Orthodontists April 30, 2016 Clinic for Aging Research and Education Institute for Memory Impairments
More informationClinical course of neuropathologically confirmed frontal-variant Alzheimer s disease
Clinical course of neuropathologically confirmed frontal-variant Alzheimer s disease Kirsten I Taylor, Alphonse Probst, André R Miserez, Andreas U Monsch and Markus Tolnay* CASE STUDY SUMMARY Background
More informationVisual Hallucinations in Dementia: A Prospective Community-Based Study With Autopsy
Visual Hallucinations in Dementia: A Prospective Community-Based Study With Autopsy Debby Tsuang, M.D., M.Sc., Eric B. Larson, M.D., M.P.H., Elizabeth Bolen, B.S., Mary Lou Thompson, Ph.D., Elaine Peskind,
More informationDementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada
Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends
More informationPrevention, health promotion & early intervention in dementia
Prevention, health promotion & early intervention in dementia Alzheimer New Zealand Conference 2014 Steve Iliffe Professor of Primary Care & Older People University College London Rotorua, New Zealand
More informationIan McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University
Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Design of trials in DLB and PDD What has been learnt from previous trials in these indications and other dementias? Overview
More informationWhat s New in Dementia?
What s New in Dementia? Howard Rosen Professor, Department of Neurology UCSF and Aging Center Disclosure Biogen pharmaceuticals Small grant for clinical trials planning Dementia is a growing source of
More informationMultistate Markov chains and their application to the Biologically Resilient Adults in Neurological Studies cohort
University of Kentucky UKnowledge Theses and Dissertations--Epidemiology and Biostatistics College of Public Health 2013 Multistate Markov chains and their application to the Biologically Resilient Adults
More informationEPIDEMIOLOGY AND RISK FACTORS OF DEMENTIA
v2 EPIDEMIOLOGY AND RISK FACTORS OF DEMENTIA See end of article for authors affiliations Correspondence to: W M van der Flier, Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center,
More information3/6/2019 DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING FINANCIAL DISCLOSURES LEARNING OBJECTIVES
DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING MILTA LITTLE, DO, CMD DUKE UNIVERSITY SCHOOL OF MEDICINE FINANCIAL DISCLOSURES Dr. Little has no relevant financial disclosures to report Dr. Little will
More informationWhat is Neuropsychology?
Alzheimer s Disease Neurological Bases and Informed Behavioral Interventions Peter T. Keenan Clinical Neuropsychologist Marshfield Clinic Minocqua Center What is Neuropsychology? Science of the relationship
More informationDiagnosis and Treatment of Alzhiemer s Disease
Diagnosis and Treatment of Alzhiemer s Disease Roy Yaari, MD, MAS Director, Memory Disorders Clinic, Banner Alzheimer s Institute 602-839-6900 Outline Introduction Alzheimer s disease (AD)Guidelines -revised
More informationMild Cognitive Impairment
Mild Cognitive Impairment Victor W. Henderson, MD, MS Departments of Health Research & Policy (Epidemiology) and of Neurology & Neurological Sciences Stanford University Director, Stanford Alzheimer s
More informationWhat if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia
What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia Dementia: broad term for any acquired brain condition impairing mental function such that ADLs are impaired. Includes:
More informationNeurocognitive Disorders Research to Emerging Therapies
Neurocognitive Disorders Research to Emerging Therapies Edward Huey, MD Assistant Professor of Psychiatry and Neurology The Taub Institute for Research on Alzheimer s Disease and the Aging Brain Columbia
More informationThe Aging Brain The Aging Brain
The Aging Brain The Aging Brain R. Scott Turner, MD, PhD Director, Memory Disorders Program Professor, Department of Neurology Georgetown University Washington, DC memory.georgetown.edu rst36@georgetown.edu
More informationClinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)
Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) A. The development of multiple cognitive deficits manifested by both 1 and 2 1 1. Memory impairment 2. One (or more) of the following
More informationThe current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease
The current state of healthcare for Normal Aging, g, Mild Cognitive Impairment, & Alzheimer s Disease William Rodman Shankle, MS MD FACP Director, Alzheimer s Program, Hoag Neurosciences Institute Neurologist,
More informationDementia Past, Present and Future
Dementia Past, Present and Future Morris Freedman MD, FRCPC Division of Neurology Baycrest and University of Toronto Rotman Research Institute, Baycrest CNSF 2015 Objectives By the end of this presentation,
More informationGERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT RUTH KOHEN ASSOCIATE PROFESSOR UW DEPARTMENT OF PSYCHIATRY 5-4-2017
More informationEarly Onset Dementia From the background to the foreground
Early Onset Dementia From the background to the foreground Dr Jeremy Isaacs Consultant Neurologist St George s Hospital Excellence in specialist and community healthcare Themes of my talk The early onset
More informationOccurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research
Age and Ageing 2011; 40: 501 507 The Author 2011. Published by Oxford University Press on behalf of the British Geriatrics Society. doi: 10.1093/ageing/afr057 This is an Open Access article distributed
More informationUnequal Burden and Unparalleled Opportunities: Minorities in Alzheimer s Disease Research
Unequal Burden and Unparalleled Opportunities: Minorities in Alzheimer s Disease Research J Taylor Harden, PhD, RN Executive Director National Hartford Centers of Gerontological Nursing Excellence Agenda
More informationAssessing and Managing the Patient with Cognitive Decline
Assessing and Managing the Patient with Cognitive Decline Center of Excellence For Alzheimer s Disease for State of NY Capital Region Alzheimer s Center of Albany Medical Center Earl A. Zimmerman, MD Professor
More informationAnxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study
Edith Cowan University Research Online ECU Publications Post 2013 2014 Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study
More informationDr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen. Dr. Michael Plopper. Dr. Guerry Peavy
1 Anne State 2 3 Dr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen Dr. Michael Plopper Dr. Guerry Peavy 4 Michael Lobatz, MD Medical Director, Neurosciences Medical Director, Rehabilitation
More informationDEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD
DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive
More informationUnderstanding Dementia
Understanding Dementia Dr. Dallas Seitz MD FRCPC Assistant Professor, Department of Psychiatry, Queen s University, Kingston, Ontario, Canada What s Next Information about Dementia, Elder Care and Supports
More informationDelirium & Dementia. Nicholas J. Silvestri, MD
Delirium & Dementia Nicholas J. Silvestri, MD Outline Delirium vs. Dementia Neural pathways relating to consciousness Encephalopathy Stupor Coma Dementia Delirium vs. Dementia Delirium Abrupt onset Lasts
More informationNutrition and Water for Dementia Prevention
台日生技醫藥研討會 - 自然療法於失智症預防及照護之應用 Nutrition and Water for Dementia Prevention 胡朝榮 Chaur-Jong Hu, M.D. Professor and Direction, Department of Neurology and Dementia Center, Shuang Ho Hospital, Taipei Medical
More information8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research
The Evolving Concept of Alzheimer s Disease David S. Geldmacher, MD, FACP Warren Family Endowed Chair in Neurology Department of Neurology UAB School of Medicine Epochs of AD Research Epoch Years Key Event
More informationMOVEMENT DISORDERS AND DEMENTIA
MOVEMENT DISORDERS AND DEMENTIA FOCUS ON DEMENTIA WITH LEWY BODIES MADHAVI THOMAS MD NORTH TEXAS MOVEMENT DISORDERS INSTITUTE, INC DEMENTIA de men tia dəˈmen(t)sh(ē)ə/ nounmedicine noun: dementia a chronic
More informationDementia Basics. Welcome! What to expect and how to handle a dementia diagnosis. In partnership with Scripps Health.
Dementia Basics What to expect and how to handle a dementia diagnosis March 18, 2017 In partnership with Scripps Health Welcome! 1 Welcome Kristin Gaspar San Diego County Supervisor District 3 2 Our Mission:
More informationAssessment of People with Dementia. Leon Flicker WA Centre For Health and Ageing University of Western Australia Royal Perth Hospital 2014
Assessment of People with Dementia Leon Flicker WA Centre For Health and Ageing University of Western Australia Royal Perth Hospital 2014 Inaugural David Simmons Address Projected number of people with
More informationEarly life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study
Neurobiology of Aging 26 (2005) 341 347 Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study Kathryn P. Riley a,b,, David A. Snowdon b,c, Mark F.
More informationA Dynamic Model of Care for Late Onset Cognitive Impairment. Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong
A Dynamic Model of Care for Late Onset Cognitive Impairment Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong Outline The pathogenesis of Late life cognitive impairment A framework
More informationDEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease
What is PRESENTS DEMENTIA? WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: Memory Reasoning Planning Learning Attention Language Perception Behavior AS OF 2013 There
More informationPopulation Ageing and Care Simulation model (PACSim)
Population Ageing and Care Simulation model (PACSim) BASELINE DATASET AND MODEL CONSTRUCTION (VERSION: 241017) Andrew Kingston, Research statistician Carol Jagger, AXA Professor of Epidemiology of Ageing
More informationAlzheimer s Disease Neuroimaging Initiative
Alzheimer s Disease Neuroimaging Initiative Steering Committee Meeting April 18, 2016 Neuropathology Core John C. Morris, MD Nigel J. Cairns, PhD, FRCPath Erin Franklin, MS Table 1. Participants Autopsied
More information